Asan Medical center

Phase	Trial	Trial Status	Site Status [desc]	Drug	NCT#
2	5 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High Risk	Recruiting	Active	Imatinib	NCT05385549
2	Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)	Recruiting	Active	Belzutifan	NCT04924075
2	The Efficacy and Safety of Temozolomide in SDH-deficient GIST (GIST)	Recruiting	Active	Temozolomide	NCT05661643
2	Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor	Recruiting	Active	Rivoceranib + Paclitaxel	NCT05905887
1	A Study of NB003 in Patients With Advanced Malignancies	Active, not recruiting	Active	NB003	NCT04936178
1	A First-in-human (FIH) Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST) [Study ID: StrateGIST1]	Recruiting	Active	IDRX-42	NCT05489237